First, we at LMG Life Sciences hope all are safe and healthy as we navigate this uncertain time. We understand that many firms and companies are adjusting to the circumstances brought by the COVID-19 pandemic, and while our North America research in 2020 will continue, our aim is to be as flexible as possible with firms that wish to participate.

Research has launched and our submission deadline is set for June 1. In the past we have granted to extensions, and we will continue to be understanding with firms especially as many experience logistical constraints. Research interviews will also continue as normal into May and June through the use of virtual platforms or conference lines.

We remain optimistic that this situation will improve by the close of research this Fall, but our team will continue to monitor the status of the pandemic in the event that any official changes to the research period are warranted.

For now, we encourage an open line of communication with firms that may have any questions or specific concerns as we are all impacted by the COVID-19 pandemic.